40% of US cancer cases linked to lifestyle choices

FHS
July 15, 2024
3:40 am

Nearly 40% of cancer cases and 44% of cancer deaths in 2019 were due to modifiable risk factors, with cigarette smoking as the leading cause. This study highlights the potential to significantly reduce cancer burden through lifestyle changes.

Regenxbio gives glimpse at early Duchenne gene therapy results, plans pivotal study for accelerated approval

Regenxbio shared early biomarker results from a 12-year-old boy with Duchenne muscular dystrophy who received a higher dose of its gene therapy, and the biotech

March 6, 2024

Most Kids Getting Antibiotics for Pink Eye Against Guideline Advice

Doctors are prescribing antibiotics to most kids and teens who have pink eye, despite guidelines that discourage their use, researchers reported. More than two-thirds of

June 29, 2024

AstraZeneca posts 16% drop in Q3 2023 profit after tax

AstraZeneca’s earnings per share (EPS) on a reported basis dropped by 16% to $0.89 from $1.06 in Q3 2022. Credit: Ascannio / Shutterstock.com. AstraZeneca has

November 10, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.